CSTL FY 2019 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$772M

FY 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$52M+127.6% YoY

Gross Profit

$45M85.9% margin

Operating Income

$7M14.1% margin

Net Income

$5M10.2% margin

EPS (Diluted)

$-0.21

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$6M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$120M

Total Liabilities

$35M

Stockholders' Equity

$85M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$23M	+127.6%
Gross Profit	$45M	$17M	+154.8%
Operating Income	$7M	-$4M	+291.1%
Net Income	$5M	-$6M	+182.9%